Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 4:05 PM View:  | Solid Biosciences Inc. (SLDB) | 03-Oct-24 | Option Exercise | 3,255 | -- | -- | 3% 106.46K to 109.72K | |
| 05-Jul-24 4:05 PM View: | Solid Biosciences Inc. (SLDB) | 03-Jul-24 | Option Exercise | 3,255 | -- | -- | 3% 103.21K to 106.46K | |
| 05-Apr-24 4:45 PM View: | Solid Biosciences Inc. (SLDB) | 03-Apr-24 | Option Exercise | 3,256 | -- | -- | 3% 99.95K to 103.21K | |
| 05-Jan-24 7:02 PM View: | Solid Biosciences Inc. (SLDB) | 03-Jan-24 | Option Exercise | 15,570 | -- | -- | 18% 84.38K to 99.95K | |
| 05-Oct-23 3:13 PM View: | Solid Biosciences Inc. (SLDB) | 03-Oct-23 | Option Exercise | 15,569 | -- | -- | 23% 68.81K to 84.38K | |
| 06-Jul-23 1:40 PM View: | Solid Biosciences Inc. (SLDB) | 03-Jul-23 | Option Exercise | 15,570 | -- | -- | 29% 53.24K to 68.81K | |
| 08-Jun-23 9:15 PM View: | Solid Biosciences Inc. (SLDB) | 03-Apr-23 | Option Exercise | 15,569 | -- | -- | 41% 37.67K to 53.24K | |
| 05-Jan-23 10:00 PM View: | Solid Biosciences Inc. (SLDB) | 03-Jan-23 | Option Exercise | 1,620 | -- | -- | 4% 36.05K to 37.67K | |
| 05-Dec-22 6:02 PM View: | Solid Biosciences Inc. (SLDB) | 02-Dec-22 | Grant | 13,172 | -- | -- | 4% 343.21K to 356.38K | |
| 04-Oct-22 4:50 PM View: | Solid Biosciences Inc. (SLDB) | 03-Oct-22 | Option Exercise | 24,312 | -- | -- | 8% 318.9K to 343.21K | |
| 06-Jul-22 4:40 PM View: | Solid Biosciences Inc. (SLDB) | 03-Jul-22 | Option Exercise | 24,313 | -- | -- | 8% 294.58K to 318.9K | |
| 05-Apr-22 4:32 PM View: | Solid Biosciences Inc. (SLDB) | 03-Apr-22 | Option Exercise | 24,313 | -- | -- | 9% 270.27K to 294.58K | |
| 14-Dec-20 4:22 PM View: | Solid Biosciences Inc. (SLDB) | 10-Dec-20 | Grant | 270,270 | $3.70 | $999,999.00 | 100% 0 to 270.27K | 85% |
| 03-Jul-18 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Jun-18 | Option Exercise | 23,375 | $131.89 | $3,082,930.00 | 45% 52.01K to 75.38K | |
| 03-Jul-18 4:25 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Jun-18 | Market Option Sale (Planned) | 23,375 | $166.30 | $3,887,170.00 | (31%) 75.38K to 52.01K | (5%) |
| 26-Jun-18 5:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 22-Jun-18 | Option Exercise | 4,250 | $109.14 | $463,845.00 | 8% 52.01K to 56.26K | |
| 26-Jun-18 5:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 22-Jun-18 | Market Option Sale (Planned) | 4,250 | $160.00 | $680,000.00 | (8%) 56.26K to 52.01K | (9%) |
| 19-Jun-18 4:19 PM View: | Acorda Therapeutics, Inc. (ACOR) | 15-Jun-18 | Option Exercise | 25,000 | $18.46 | $461,500.00 | 100% 0 to 25.0K | |
| 19-Jun-18 4:19 PM View: | Acorda Therapeutics, Inc. (ACOR) | 15-Jun-18 | Market Option Sale (Planned) | 25,000 | $31.42 | $785,568.00 | (100%) 25.0K to 0 | 98% |
| 14-Jun-18 8:34 AM View: | Infinity Pharmaceuticals, I... (INFI) | 12-Jun-18 | Grant | 22,857 | $1.75 | $39,999.80 | 99% 22.99K to 45.84K | 21% |
| 16-May-18 5:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-May-18 | Market Sale (Planned) | 217 | $155.78 | $33,804.30 | (< 1%) 52.22K to 52.01K | (12%) |
| 15-May-18 4:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-18 | Option Exercise | 4,096 | $88.90 | $364,148.00 | 8% 52.01K to 56.1K | |
| 15-May-18 4:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-18 | Market Option Sale (Planned) | 4,096 | $155.00 | $634,880.00 | (7%) 56.1K to 52.01K | (13%) |
| 04-May-18 5:50 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-May-18 | Option Exercise | 10,000 | $20.16 | $201,600.00 | 100% 0 to 10.0K | |
| 04-May-18 5:50 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-May-18 | Market Option Sale (Planned) | 10,000 | $23.72 | $237,175.00 | (100%) 10.0K to 0 | 97% |
| 27-Apr-18 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Apr-18 | Option Exercise | 53,125 | $108.65 | $5,771,990.00 | 102% 52.01K to 105.13K | |
| 27-Apr-18 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Apr-18 | Market Option Sale (Planned) | 51,000 | $160.12 | $8,166,120.00 | (49%) 105.13K to 54.13K | (9%) |
| 27-Apr-18 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Apr-18 | Market Sale (Planned) | 2,125 | $160.12 | $340,255.00 | (4%) 54.13K to 52.01K | (9%) |
| 27-Apr-18 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Apr-18 | Option Exercise | 14,172 | $84.45 | $1,196,790.00 | 20% 69.8K to 83.97K | |
| 27-Apr-18 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Apr-18 | Market Option Sale (Planned) | 16,297 | $155.33 | $2,531,380.00 | (19%) 83.97K to 67.68K | (13%) |
| 27-Apr-18 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Apr-18 | Market Sale (Planned) | 15,671 | $155.33 | $2,434,150.00 | (23%) 67.68K to 52.01K | (13%) |
| 08-Feb-18 6:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-18 | Grant | 23,607 | -- | -- | 51% 46.19K to 69.8K | |
| 17-Jan-18 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Jan-18 | Option Exercise | 2,125 | $96.87 | $205,849.00 | (4%) 50.44K to 48.32K | |
| 17-Jan-18 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Jan-18 | Market Sale (Planned) | 2,125 | $157.29 | $334,232.00 | (4%) 48.32K to 46.19K | (11%) |
| 17-Nov-17 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-17 | Market Sale (Planned) | 7 | $147.29 | $1,031.03 | (< 1%) 46.2K to 46.19K | (19%) |
| 07-Nov-17 5:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Nov-17 | Option Exercise | 4,250 | $77.31 | $328,568.00 | 9% 46.19K to 50.44K | |
| 07-Nov-17 5:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Nov-17 | Market Option Sale (Planned) | 4,250 | $150.00 | $637,500.00 | (8%) 50.44K to 46.19K | (17%) |
| 07-Nov-17 5:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Nov-17 | Option Exercise | 2,155 | $91.05 | $196,213.00 | 5% 46.19K to 48.35K | |
| 07-Nov-17 5:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Nov-17 | Market Option Sale (Planned) | 2,155 | $150.00 | $323,250.00 | (4%) 48.35K to 46.19K | (17%) |
| 31-Oct-17 6:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Oct-17 | Market Sale (Planned) | 75,000 | $145.07 | $10,879,900.00 | (62%) 121.19K to 46.19K | (20%) |
| 18-Oct-17 5:41 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Oct-17 | Option Exercise | 2,125 | $96.87 | $205,849.00 | 2% 121.19K to 123.32K | |
| 18-Oct-17 5:41 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Oct-17 | Market Option Sale (Planned) | 2,125 | $155.61 | $330,671.00 | (2%) 123.32K to 121.19K | (12%) |
| 09-Aug-17 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Aug-17 | Option Exercise | 4,250 | $77.31 | $328,568.00 | 4% 121.19K to 125.44K | |
| 09-Aug-17 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Aug-17 | Market Option Sale (Planned) | 4,250 | $155.39 | $660,415.00 | (3%) 125.44K to 121.19K | (12%) |
| 04-Aug-17 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Aug-17 | Option Exercise | 2,155 | $91.05 | $196,213.00 | 2% 121.19K to 123.35K | |
| 04-Aug-17 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Aug-17 | Market Option Sale (Planned) | 2,155 | $154.17 | $332,236.00 | (2%) 123.35K to 121.19K | (13%) |
| 02-Aug-17 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Jul-17 | Option Exercise | 2,125 | $83.36 | $177,140.00 | 2% 121.19K to 123.32K | |
| 02-Aug-17 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Jul-17 | Market Option Sale (Planned) | 2,125 | $152.88 | $324,865.00 | (2%) 123.32K to 121.19K | (14%) |
| 21-Jul-17 8:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Jul-17 | Market Sale (Planned) | 10,350 | $160.72 | $1,663,410.00 | (8%) 131.54K to 121.19K | (9%) |
| 21-Jul-17 8:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-17 | Option Exercise | 123,400 | $84.11 | $10,379,700.00 | 94% 131.54K to 254.94K |